Allan has more than 35 years of engineering and manufacturing experience including 30 years in the biotechnology industry. His biotech experience includes working for major biopharmaceutical companies such as Chiron and Baxter Healthcare. His expertise includes large-scale bacterial fermentation, mammalian cell culture, vaccines, downstream processing, protein purification and immobilization and Current Good Manufacturing Practice facility design, operations and assessment.
NextGen Now – The Future of ATMP Facilities
ATMP processes have fallen back on manual operations to accommodate the patient specific scale, but what will these facilities look like in five years? The race for process closure and automated solutions has already begun. Don’t miss out as CRB discusses what will drive the industry to reduced operating costs, more efficient staff utilization and improved reliability and product reproducibility.View All Members